🇺🇸 FDA
Pipeline program

survodutide

1404-0040

Phase 3 other active

Quick answer

survodutide for Obesity is a Phase 3 program (other) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim
Indication
Obesity
Phase
Phase 3
Modality
other
Status
active

Clinical trials